FEB 16, 2017 12:02 PM PST

A New Blood Test to Diagnose Parkinson's Disease

WRITTEN BY: Xuan Pham

Despite being well-known in the medical arena, diagnosing Parkinson’s disease correctly can be quite challenging since symptoms of this disease are often confused with other similar neurological diseases. Now, researchers from the Lund University in Sweden have developed a simple blood test that can differentiate true Parkinson’s disorder (PD) from atypical parkinsonian disorders (APD).

Parkinson’s disease is characterized by progressive neurodegeneration, causing severe impairments in movement. Most often, the disease is associated with uncontrolled tremors; however, patients can also suffer from muscle stiffness and the difficulty moving or speaking. Because the disease is progressive, symptoms worsen over time. There are no cures, but medications can improve some of the symptoms, especially if the disease is diagnosed at early stages.

Unfortunately, there are other neurological disorders that mimic the symptoms of Parkinson’s disease, making it difficult for physicians to diagnose by examination alone. "This can be very challenging, especially during the early stages of the diseases and if the responsible doctor is not a neurologist specialized in movement disorders," said Dr. Oskar Hansson, an associate professor at Lund University in Sweden, and the study’s lead author.

Hansson stresses the importance of distinguishing Parkinson’s disease from atypical parkinsonian disorders, as the wrong diagnosis could delay treatment and worsen the outcome. In particular, people with APD "usually have a much worse prognosis, with faster disease progression, (with) more disabling symptoms,” Hansson said. Furthermore, people with APD don’t respond to dopamine-targeted therapies usually prescribed for Parkinson’s disease. Thus, correct diagnosis is key.

The new blood test relies on detection of a biomarker known as neurofilament light chain (NfL). This protein is shed into the spinal fluid when nerve cells die. Hansson and colleagues investigated whether NfL can also be picked up in blood, samples which would be much less invasive to acquire as compared to a spinal tap for spinal fluid.

In a cohort of 244 people, some with Parkinson’s disease, some with atypical parkinsonian disorder, and some healthy controls, the team found differences in the levels of NfL in blood. Particularly, people with atypical parkinsonian disorder had the highest level of NfL, followed by people with Parkinson’s disease. The difference is enough, the team says, to help doctors distinguish between the two diseases with higher confidence.

Hansson and his colleages believe the blood test will soon be "in the diagnostic work-up of patients with parkinsonism by most doctors who are not very specialized with these movement disorders." As misdiagnosis for this disease may be extremely costly for patients and family members, he hopes the test will improve diagnosis as well as outcome for the patients.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 12, 2020
Cancer
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
AUG 12, 2020
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
Since the 1940s, chemotherapy has been a primary treatment option for cancer. The late 20th century brought a new type o ...
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
OCT 29, 2020
Clinical & Molecular DX
Skin Deep: A Novel Test for Parkinson's
OCT 29, 2020
Skin Deep: A Novel Test for Parkinson's
In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regi ...
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
NOV 12, 2020
Clinical & Molecular DX
Study Shows 1 in 5 COVID Tests Are False Positives
NOV 12, 2020
Study Shows 1 in 5 COVID Tests Are False Positives
  A study published in The BMJ has brought to light that the rapid finger-prick COVID-19 test may not be quite as r ...
Loading Comments...